Here are articles from the latest issue of American Health & Drug Benefits. AHDB is a peer-reviewed journal for 30,000 decision makers in health plans, PBMs, Medicare, Medicaid, and the pharma and biotech industries:

Orphan Drug Pricing and Payer Management in the United States: Are We Approaching the Tipping Point? by Rebecca Hyde and Diana Dobrovolny, with Stakeholder Perspective by Kavita V. Nair, PhD.

Physicians’ Perceptions of Reimbursement as a Barrier to Comprehensive Diabetes Care by Alyssa Pozniak, PhD; Lois Olinger, MA; and Victoria Shier, MA, with Stakeholder Perspective by Gary M. Owens, MD

Hypertension Management: An Update by Quang Nguyen, DO; Joann Dominguez, MD; Loida Nguyen, PharmD; and Nageshwara Gullapalli, MD.

Competition from Biosimilars an Incentive for Innovation by Dalia Buffery, MA, ABD

Emerging Trends in Breast Cancer Management by Caroline Helwick

Rheumatology Pipeline Boasts Innovation, ID Line Is Drying Up: ACR/IDSA 2009 by Alice Goodman

Cardiology Pipeline Is Promising: AHA 2009 by Wayne Kuznar

Learn More:

American Health & Drug Benefits is available in print and online at To view the current or past issues or download in PDF format, click here.

Kip Piper is health policy editor of American Health & Drug Benefits.